Effect of selected local medicinal plants on the asexual blood stage of chloroquine resistant Plasmodium falciparum.

Mohd Ridzuan Mohd Abd Razak,Siti Habsah Shiekh Zahari,Mohd Isa Wasiman,Zakiah Ismail,Adlin Afzan,Nur Fasihah Amir Jalaluddin,Noor Rain Abdullah,Rosnani Ali

doi:10.1186/1472-6882-14-492

Mohd Ridzuan Mohd Abd Razak, Siti Habsah Shiekh Zahari + Show 6 more

Open Access

https://doi.org/10.1186/1472-6882-14-492

Copy DOI

Abstract

BackgroundThe development of resistant to current antimalarial drugs is a major challenge in achieving malaria elimination status in many countries. Therefore there is a need for new antimalarial drugs. Medicinal plants have always been the major source for the search of new antimalarial drugs. The aim of this study was to screen selected Malaysian medicinal plants for their antiplasmodial properties.MethodsEach part of the plants were processed, defatted by hexane and sequentially extracted with dichloromethane, methanol and water. The antiplasmodial activities of 54 plant extracts from 14 species were determined by Plasmodium falciparum Histidine Rich Protein II ELISA technique. In order to determine the selectivity index (SI), all plant extracts demonstrating a good antiplasmodial activity were tested for their cytotoxicity activity against normal Madin-Darby Bovine Kidney (MDBK) cell lines by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay.ResultsTwenty three extracts derived from Curcuma zedoaria (rhizome), Curcuma aeruginosa (rhizome), Alpinia galanga (rhizome), Morinda elliptica (leaf), Curcuma mangga (rhizome), Elephantopus scaber (leaf), Vitex negundo (leaf), Brucea javanica (leaf, root and seed), Annona muricata (leaf), Cinnamomun iners (leaf) and Vernonia amygdalina (leaf) showed promising antiplasmodial activities against the blood stage chloroquine resistant P. falciparum (EC50 < 10 μg/ml) with negligible toxicity effect to MDBK cells in vitro (SI ≥10).ConclusionThe extracts belonging to eleven plant species were able to perturb the growth of chloroquine resistant P. falciparum effectively. The findings justified the bioassay guided fractionation on these plants for the search of potent antimalarial compounds or formulation of standardized extracts which may enhance the antimalarial effect in vitro and in vivo.

Highlights

The development of resistant to current antimalarial drugs is a major challenge in achieving malaria elimination status in many countries
Antiplasmodial activity against CQ resistant P. falciparum, K1 strain A total of 54 extracts from different parts of 14 plant species (Table 2) were tested for antiplasmodial activity against chloroquine resistant P. falciparum by using HRP2 assay in vitro
The antiplasmodial HRP2 assay on the plant extracts were performed in parallel with the standard antimalarial drugs such as CQ, Q, Mef and Art which act as a control for the validity of the assay (Table 3)

Summary

Introduction

The development of resistant to current antimalarial drugs is a major challenge in achieving malaria elimination status in many countries. Medicinal plants have always been the major source for the search of new antimalarial drugs. The resistance Plasmodium falciparum to common antimalarial drugs such as chloroquine, sulfadoxine-pyrimethamine [1,2,3] and artemisinin [4] have been reported. In response to this situation, as recommended by World Health Organization (WHO), Malaysian government has changed its first line antimalarial drug regimen to artemisinin-based combination therapy (ACT) such as the use of fixed dose artemether-lumefantrine combination (Riamet®) in the Plants have always been the main source for the search of new antimalarial drugs. Screening the plant extracts for antimalarial properties prior to bioassay guided fractionation and potent compound isolation is important

Objectives

Methods

Results

Discussion

Conclusion